BPG is committed to discovery and dissemination of knowledge
Featured Articles
Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
Browse: 187   Download: 553   Issue Date: 2024-08-22
Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
Browse: 253   Download: 594   Issue Date: 2024-08-22
Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
Browse: 248   Download: 527   Issue Date: 2024-08-22
Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
Browse: 195   Download: 388   Issue Date: 2024-08-22
Rocahepevirus ratti: An underrecognised cause of acute hepatitis
Browse: 161   Download: 440   Issue Date: 2024-08-22
Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
Browse: 293   Download: 678   Issue Date: 2024-07-26
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
Browse: 307   Download: 773   Issue Date: 2024-07-26
Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
Browse: 290   Download: 579   Issue Date: 2024-07-26
Interleukin-mediated therapies in liver diseases and comorbidity effects
Browse: 303   Download: 662   Issue Date: 2024-07-26
Roles of transforming growth factor-β signaling in liver disease
Browse: 338   Download: 578   Issue Date: 2024-07-26
Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
Browse: 240   Download: 677   Issue Date: 2024-06-27
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
Browse: 210   Download: 858   Issue Date: 2024-06-27
Importance of the gut microbiota in the gut-liver axis in normal and liver disease
Browse: 196   Download: 529   Issue Date: 2024-06-27
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
Browse: 193   Download: 489   Issue Date: 2024-06-27
Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
Browse: 185   Download: 520   Issue Date: 2024-06-27
Ornithine aspartate effects on bacterial composition and metabolic pathways in a rat model of steatotic liver disease
Browse: 286   Download: 974   Issue Date: 2024-05-27
Current concepts in the management of non-cirrhotic non-malignant portal vein thrombosis
Browse: 274   Download: 671   Issue Date: 2024-05-27
Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?
Browse: 207   Download: 530   Issue Date: 2024-05-27
Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease
Browse: 239   Download: 576   Issue Date: 2024-05-27
Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
Browse: 269   Download: 595   Issue Date: 2024-05-27